Sovereignty in bioproduction

We believe that every country should have access to local biomanufacturing capabilities. Developed in Canada, Aramis' platform is designed to be deployed globally, to strengthen biological sovereignty, supply chain resilience, and access to biosolutions around the world.

  • Development of modular production units allowing rapid and adaptable deployment in different regions of the world. Rapid response demonstrated during the COVID-19 pandemic, illustrating the agility and flexibility of the technology platform.
  • Strengthening national autonomy in biodefence through local capacity to produce vaccines, therapeutics and other strategic biosolutions.
  • Creation of local value chains in collaboration with industrial, agricultural and manufacturing partners in each territory.
  • Repeatable model to build national biomanufacturing capabilities while benefiting from proven, standardized technology.